PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.68% | 2.83% | 16.06% | 4.50% | -11.13% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -40.84% | -5.40% | 254.43% | -127.58% | 308.66% |
| Total Other Non-Cash Items | 227.44% | -28.05% | -19.60% | 346.27% | -69.26% |
| Change in Net Operating Assets | 113.03% | -23.05% | 27.22% | 211.41% | 45.63% |
| Cash from Operations | 36.12% | -18.07% | 37.41% | 35.00% | -0.76% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -1,138.86% | 19.08% | -84.15% | 94.85% | -527.51% |
| Issuance of Common Stock | -88.34% | -78.99% | 215.57% | -13.97% | -79.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -1,852.29% | -116.12% | 1,647.89% | -75.78% | -86.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -218.01% | -1,084.12% | 109.05% | 29.99% | -373.74% |